COVID-19 in Multiple Sclerosis: Assessment of Risk Factors

What Are the Risk Factors for COVID-19 in MS Patients?

COVID-19 occurs more often in systemic and autoimmune disorders, including multiple sclerosis (MS). Studies indicate that certain risk factors, such as immunosuppressive therapies or advanced stages of MS, may increase the chance of infections. However, COVID-19 vaccination has been shown to lower the risk of complications. More research is still required to fully understand how COVID-19 affects patients with multiple sclerosis.

If you have MS, some factors may raise the risk of COVID-19 or developing severe symptoms.

These include:

• Use of Immunosuppressive Therapy: Medications like Rituximab or Ocrelizumab can weaken the immune system, making it harder for the body to fight infections.

• Comorbidities: Conditions such as high blood pressure, diabetes, obesity, and heart disease increase the risk of severe COVID-19 in MS patients.

• Age and Disability Levels: Older adults with MS or those with mobility challenges may have reduced lung capacity, which increases their risk.

Who Are Among the Risk Groups to Develop COVID-19?

Some groups are more likely to get COVID-19 and develop severe illness because of weak immunity or high exposure risk.

• Adults Aged Over 60 Years: Older adults are more likely to contract COVID-19 than younger individuals. Around 80 percent of COVID-related deaths occur in this age group because their immunity is weaker.

• Individuals With Comorbid Conditions: People with diabetes, hypertension, cardiac disorders, and lung disease (like asthma and COPD) are more likely to get infected with COVID-19.

• Immunocompromised Individuals: People with weak immune systems due to cancer or prolonged use of immunosuppressive medications, those with autoimmune disorders, those receiving radiotherapy or chemotherapy, and organ transplant patients are more likely to develop COVID-19 and its complications.

What Are the COVID-19 Symptoms in Multiple Sclerosis?

The following are the COVID-19 symptoms in multiple sclerosis patients:

• General Symptoms

  • Fever.

  • Cough.

  • Shortness of breath.

  • Fatigue.

  • Loss of taste or smell.

• Neurological Symptoms

  • Increased fatigue.

  • Headaches.

  • Brain fog or confusion.

• Worsening MS Symptoms

  • Increased muscle weakness.

  • Difficulty walking.

Can COVID-19 Cause Multiple Sclerosis?

• There is no definitive link between COVID-19 as a direct cause of MS.

• It may trigger autoimmune responses in individuals who are genetically predisposed.

• In patients who are already diagnosed with MS, COVID-19 can worsen symptoms due to underlying risk factors, such as immunosuppressive therapies or comorbidities like hypertension and diabetes.

How Are MS Patients and COVID-19 Vaccination Linked?

• COVID-19 vaccination does not cause MS.

• They reduce the risk of severe illness and relapses in MS patients.

• Vaccination strategies prioritize safety and the prevention of complications.

What Are the Effects of COVID-19 on Patients Suffering from Multiple Sclerosis?

Apart from the traditional effects, the effect of COVID-19 on patients living with MS may be severe. This is attributed to the involvement of the neurological systems:

• Disruption of the blood-brain barrier:

  • In multiple sclerosis patients, the blood-brain barrier is a security gate for the brain. It protects the brain by keeping harmful substances out while allowing essential nutrients to pass through. It is already disrupted.

  • The elevation of spike proteins (a specific part of a virus that helps it infect cells) in COVID-19 patients may further damage it, leading to injury of cells that line blood vessels.

• Increased inflammation: Elevated levels of inflammatory chemicals contribute to nerve cell damage and demyelination. This can lead to serious neurological issues like:

  • Sensory loss.

  • Memory impairment.

  • Cognitive difficulties.

Conclusion:

COVID-19 is more common in patients with systemic and autoimmune disorders. For MS patients, the infection can worsen neurological symptoms. Moreover, the application of certain drugs to multiple sclerosis patients may increase disease susceptibility and impact the effectiveness of the vaccine. Further research is required, but vaccination remains a meaningful way to reduce the risk of severe illness in MS patients.

Key Takeaways:

• MS patients have a higher risk of severe COVID-19, especially if they are older, have comorbidities, or use immunosuppressive drugs.

• Vaccination is safe and very important for MS patients, as it lowers the chances of severe infection and complications.

If you or anyone you know has similar symptoms, consult our neurologist at iCliniq.